Search results
Results From The WOW.Com Content Network
As a result, Moderna Inc. (NASDAQ:MRNA) was removed from the index. Year to date, Moderna stock has plunged over 60%, with a 52-week low-high of $35.8-$170.47, as per data from Benzinga Pro.
Tuesday, Moderna Inc (NASDAQ:MRNA) stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro. On Friday, Moderna announced ongoing support from the U.S. Department ...
On Monday, Merck & Co Inc (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) announced the initiation of INTerpath-009, a pivotal Phase 3 trial of V940 (mRNA-4157). V940 is an investigational ...
Moderna (MRNA) closed at $122.15 in the latest trading session, marking a -0.07% move from the prior day. Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know Skip to main content
Moderna (MRNA) closed at $222.89 in the latest trading session, marking a +0.68% move from the prior day.
Moderna (NASDAQ:MRNA) is reaping the rewards of its successful Covid-19 vaccine, pushing MRNA stock higher and higher. It is now winning more contracts to deliver its vaccine and analysts are ...
Moderna held its annual R&D day this week. Moderna's (NASDAQ: MRNA) struggles may last a little longer than expected. The biotech company had seen both sales and its stock price plummet as demand ...
Monday, Moderna, Inc.’s (NASDAQ:MRNA) manufacturing facility in Laval, Quebec, received a Drug Establishment License (DEL) from Health Canada. This certification affirms the facility’s ...